Amgen heads into Q1 earnings with growth from key drugs offset by pricing pressure, patent losses, and biosimilar competition.

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Microsoft Corporation. Read 's Market Analysis on Investing.com ...

Potential Health Risks Identified The analysis also examined safety concerns. Long-term studies in adolescents showed that high-potency cannabis may be associated with higher rates of psychotic ...